1. Home
  2. ATLO vs IMAB Comparison

ATLO vs IMAB Comparison

Compare ATLO & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLO
  • IMAB
  • Stock Information
  • Founded
  • ATLO 1903
  • IMAB 2014
  • Country
  • ATLO United States
  • IMAB United States
  • Employees
  • ATLO N/A
  • IMAB N/A
  • Industry
  • ATLO Major Banks
  • IMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATLO Finance
  • IMAB Health Care
  • Exchange
  • ATLO Nasdaq
  • IMAB Nasdaq
  • Market Cap
  • ATLO 170.8M
  • IMAB 200.9M
  • IPO Year
  • ATLO N/A
  • IMAB 2020
  • Fundamental
  • Price
  • ATLO $19.06
  • IMAB $4.87
  • Analyst Decision
  • ATLO
  • IMAB Strong Buy
  • Analyst Count
  • ATLO 0
  • IMAB 3
  • Target Price
  • ATLO N/A
  • IMAB $6.33
  • AVG Volume (30 Days)
  • ATLO 12.3K
  • IMAB 4.2M
  • Earning Date
  • ATLO 08-08-2025
  • IMAB 05-15-2025
  • Dividend Yield
  • ATLO 4.56%
  • IMAB N/A
  • EPS Growth
  • ATLO 43.95
  • IMAB N/A
  • EPS
  • ATLO 1.53
  • IMAB N/A
  • Revenue
  • ATLO $57,731,000.00
  • IMAB N/A
  • Revenue This Year
  • ATLO N/A
  • IMAB N/A
  • Revenue Next Year
  • ATLO N/A
  • IMAB N/A
  • P/E Ratio
  • ATLO $12.61
  • IMAB N/A
  • Revenue Growth
  • ATLO 12.59
  • IMAB N/A
  • 52 Week Low
  • ATLO $15.69
  • IMAB $0.60
  • 52 Week High
  • ATLO $19.64
  • IMAB $5.90
  • Technical
  • Relative Strength Index (RSI)
  • ATLO 60.92
  • IMAB 75.47
  • Support Level
  • ATLO $18.30
  • IMAB $3.30
  • Resistance Level
  • ATLO $19.41
  • IMAB $3.94
  • Average True Range (ATR)
  • ATLO 0.38
  • IMAB 0.58
  • MACD
  • ATLO 0.07
  • IMAB 0.23
  • Stochastic Oscillator
  • ATLO 74.84
  • IMAB 76.12

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

Share on Social Networks: